This is the supplier profile page of ALPHA START LTD, where buyers can explore products, connect directly with the supplier for pricing inquiries.
1.1
7TH FLOOR, EGL TOWE
Add Favorite
Report Supplier
Business Description
We are now part of invoX Pharma
We are developing next generation therapies to transform the lives of patients with cancer and other serious diseases.
Our goal is to help patients live longer, allowing for quality time with family and friends, while maintaining a high quality of life.
Our advanced pipeline of immuno-therapies are being designed to enable a paradigm shift in therapies for cancer and other serious diseases.
F-star is an innovation focused biotech company dedicated to delivering next-generation multispecific antibody therapeutics so more people with cancer and other serious diseases can live longer and improved lives.
F-star’s proprietary tetravalent bispecific antibody format is designed to ensure focused, potent and safe activation of the immune system.
Our first-in-class and best-in-class drug candidates are designed to work with a patient’s immune system to stop tumors from evading the body’s defense mechanisms.
Our pioneering tetravalent or 2+2 bispecific antibody approach creates two new sites for antigen binding. We call this tetravalency. It’s an elegant solution on the natural human antibody format that does not disrupt its structure or functions.
We are focused on some of the most promising immuno-oncology targets in drug development, including LAG-3 and CD137, targeting a large and growing patient population with unmet medical need.
The strong dual-immune activation enabled by our tetravalent bispecific binding, we believe, will be more effective and enable a transformational shift in patient outcomes.
Business Overview
Avg Response Time
≤ 1h
Trade Capabilities
Business Terms
Trade Ability
